Saul Kato, Ph.D.

University of California, San Francisco, San Francisco, CA 
dynamical systems
"Saul Kato"
Mean distance: 13.75 (cluster 6)


Sign in to add mentor
Larry F. Abbott grad student 2008-2013 Columbia
 (Temporal Processing by Caenorhabditis elegans Sensory Neurons.)
Cori Bargmann grad student 2008-2013 Rockefeller
Manuel Zimmer post-doc Research Institute of Molecular Pathology
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kato S, Wakabayashi H, Nakagawa T, et al. (2020) Teriparatide improves pain-related behavior and prevents bone loss in ovariectomized mice. Journal of Orthopaedic Surgery (Hong Kong). 28: 2309499019893194
Chen Y, Hui SP, Miura Y, et al. (2019) Multivariate analysis for molecular species of cholesteryl ester in the human serum. Analytical Sciences : the International Journal of the Japan Society For Analytical Chemistry
Hisamatsu T, Matsumoto T, Watanabe K, et al. (2019) Concerns and side effects of azathioprine during adalimumab induction and maintenance therapy for Japanese patients with Crohn's disease: a sub-analysis of a prospective randomized clinical trial (DIAMOND study). Journal of Crohn's & Colitis
Nakagawa T, Wakabayashi H, Naito Y, et al. (2018) The effects of bisphosphonate on pain-related behavior and immunohistochemical analyses in hindlimb-unloaded mice. Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association. 23: 1063-1069
Watanabe K, Matsumoto T, Hisamatsu T, et al. (2017) Clinical and pharmacokinetic factors associated with adalimumab-induced mucosal healing in patients with Crohn's disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
Nakase H, Motoya S, Matsumoto T, et al. (2017) Significance of measurement of serum trough level and anti-drug antibody of adalimumab as personalised pharmacokinetics in patients with Crohn's disease: a subanalysis of the DIAMOND trial. Alimentary Pharmacology & Therapeutics
Naito Y, Wakabayashi H, Kato S, et al. (2017) Alendronate inhibits hyperalgesia and suppresses neuropeptide markers of pain in a mouse model of osteoporosis. Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association
Watanabe K, Matsumoto T, Motoya S, et al. (2017) DOP071 Comparison of endoscopic responses to adalimumab monotherapy and combination therapy with azathioprine in patients with Crohn's disease: a sub-analysis of DIAMOND trial. Journal of Crohn's & Colitis. 11: S68
Motoya S, Nakase H, Matsumoto T, et al. (2017) P523 Association between pharmacokinetics of adalimumab and disease outcome in Japanese patients with biologics naïve Crohn's disease: a subanalysis of DIAMOND trial. Journal of Crohn's & Colitis. 11: S345-S346
Matsumoto T, Motoya S, Watanabe K, et al. (2016) Adalimumab monotherapy and a combination with azathioprine for Crohn's disease: A prospective, randomized trial. Journal of Crohn's & Colitis
See more...